Research ExplorerPublicationsIntravenous Artesunate Reduces Parasite Clearance Time, Dura...

Intravenous Artesunate Reduces Parasite Clearance Time, Duration of Intensive Care, and Hospital Treatment in Patients With Severe Malaria in Europe: The TropNet Severe Malaria Study

Standard

Intravenous Artesunate Reduces Parasite Clearance Time, Duration of Intensive Care, and Hospital Treatment in Patients With Severe Malaria in Europe: The TropNet Severe Malaria Study. / Kurth, Florian; Develoux, Michel; Mechain, Matthieu; Clerinx, Jan; Antinori, Spinello; Gjørup, Ida E; Gascon, Joaquím; Mørch, Kristine; Nicastri, Emanuele; Ramharter, Michael; Bartoloni, Alessandro; Visser, Leo; Rolling, Thierry; Zanger, Philipp; Calleri, Guido; Salas-Coronas, Joaquín; Nielsen, Henrik; Just-Nübling, Gudrun; Neumayr, Andreas; Hachfeld, Anna; Schmid, Matthias L; Antonini, Pietro; Pongratz, Peter; Kern, Peter; Saraiva da Cunha, José; Soriano-Arandes, Antoni; Schunk, Mirjam; Suttorp, Norbert; Hatz, Christoph; Zoller, Thomas; TropNet Severe Malaria Investigator Group.

In: CLIN INFECT DIS, Vol. 61, No. 9, 01.11.2015, p. 1441-4.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Kurth, F, Develoux, M, Mechain, M, Clerinx, J, Antinori, S, Gjørup, IE, Gascon, J, Mørch, K, Nicastri, E, Ramharter, M, Bartoloni, A, Visser, L, Rolling, T, Zanger, P, Calleri, G, Salas-Coronas, J, Nielsen, H, Just-Nübling, G, Neumayr, A, Hachfeld, A, Schmid, ML, Antonini, P, Pongratz, P, Kern, P, Saraiva da Cunha, J, Soriano-Arandes, A, Schunk, M, Suttorp, N, Hatz, C, Zoller, T & TropNet Severe Malaria Investigator Group 2015, 'Intravenous Artesunate Reduces Parasite Clearance Time, Duration of Intensive Care, and Hospital Treatment in Patients With Severe Malaria in Europe: The TropNet Severe Malaria Study', CLIN INFECT DIS, vol. 61, no. 9, pp. 1441-4. https://doi.org/10.1093/cid/civ575

APA

Kurth, F., Develoux, M., Mechain, M., Clerinx, J., Antinori, S., Gjørup, I. E., Gascon, J., Mørch, K., Nicastri, E., Ramharter, M., Bartoloni, A., Visser, L., Rolling, T., Zanger, P., Calleri, G., Salas-Coronas, J., Nielsen, H., Just-Nübling, G., Neumayr, A., ... TropNet Severe Malaria Investigator Group (2015). Intravenous Artesunate Reduces Parasite Clearance Time, Duration of Intensive Care, and Hospital Treatment in Patients With Severe Malaria in Europe: The TropNet Severe Malaria Study. CLIN INFECT DIS, 61(9), 1441-4. https://doi.org/10.1093/cid/civ575

Vancouver

Kurth F, Develoux M, Mechain M, Clerinx J, Antinori S, Gjørup IE et al. Intravenous Artesunate Reduces Parasite Clearance Time, Duration of Intensive Care, and Hospital Treatment in Patients With Severe Malaria in Europe: The TropNet Severe Malaria Study. CLIN INFECT DIS. 2015 Nov 1;61(9):1441-4. https://doi.org/10.1093/cid/civ575

Bibtex

@article{7b4d35aca9c84f54b4355ab874399722,
title = "Intravenous Artesunate Reduces Parasite Clearance Time, Duration of Intensive Care, and Hospital Treatment in Patients With Severe Malaria in Europe: The TropNet Severe Malaria Study",
abstract = "Intravenous artesunate improves survival in severe malaria, but clinical trial data from nonendemic countries are scarce. The TropNet severe malaria database was analyzed to compare outcomes of artesunate vs quinine treatment. Artesunate reduced parasite clearance time and duration of intensive care unit and hospital treatment in European patients with imported severe malaria.",
author = "Florian Kurth and Michel Develoux and Matthieu Mechain and Jan Clerinx and Spinello Antinori and Gj{\o}rup, {Ida E} and Joaqu{\'i}m Gascon and Kristine M{\o}rch and Emanuele Nicastri and Michael Ramharter and Alessandro Bartoloni and Leo Visser and Thierry Rolling and Philipp Zanger and Guido Calleri and Joaqu{\'i}n Salas-Coronas and Henrik Nielsen and Gudrun Just-N{\"u}bling and Andreas Neumayr and Anna Hachfeld and Schmid, {Matthias L} and Pietro Antonini and Peter Pongratz and Peter Kern and {Saraiva da Cunha}, Jos{\'e} and Antoni Soriano-Arandes and Mirjam Schunk and Norbert Suttorp and Christoph Hatz and Thomas Zoller and {TropNet Severe Malaria Investigator Group}",
note = "{\textcopyright} The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.",
year = "2015",
month = nov,
day = "1",
doi = "10.1093/cid/civ575",
language = "English",
volume = "61",
pages = "1441--4",
journal = "CLIN INFECT DIS",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "9",

}

RIS

TY - JOUR

T1 - Intravenous Artesunate Reduces Parasite Clearance Time, Duration of Intensive Care, and Hospital Treatment in Patients With Severe Malaria in Europe: The TropNet Severe Malaria Study

AU - Kurth, Florian

AU - Develoux, Michel

AU - Mechain, Matthieu

AU - Clerinx, Jan

AU - Antinori, Spinello

AU - Gjørup, Ida E

AU - Gascon, Joaquím

AU - Mørch, Kristine

AU - Nicastri, Emanuele

AU - Ramharter, Michael

AU - Bartoloni, Alessandro

AU - Visser, Leo

AU - Rolling, Thierry

AU - Zanger, Philipp

AU - Calleri, Guido

AU - Salas-Coronas, Joaquín

AU - Nielsen, Henrik

AU - Just-Nübling, Gudrun

AU - Neumayr, Andreas

AU - Hachfeld, Anna

AU - Schmid, Matthias L

AU - Antonini, Pietro

AU - Pongratz, Peter

AU - Kern, Peter

AU - Saraiva da Cunha, José

AU - Soriano-Arandes, Antoni

AU - Schunk, Mirjam

AU - Suttorp, Norbert

AU - Hatz, Christoph

AU - Zoller, Thomas

AU - TropNet Severe Malaria Investigator Group

N1 - © The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Intravenous artesunate improves survival in severe malaria, but clinical trial data from nonendemic countries are scarce. The TropNet severe malaria database was analyzed to compare outcomes of artesunate vs quinine treatment. Artesunate reduced parasite clearance time and duration of intensive care unit and hospital treatment in European patients with imported severe malaria.

AB - Intravenous artesunate improves survival in severe malaria, but clinical trial data from nonendemic countries are scarce. The TropNet severe malaria database was analyzed to compare outcomes of artesunate vs quinine treatment. Artesunate reduced parasite clearance time and duration of intensive care unit and hospital treatment in European patients with imported severe malaria.

U2 - 10.1093/cid/civ575

DO - 10.1093/cid/civ575

M3 - SCORING: Journal article

C2 - 26187021

VL - 61

SP - 1441

EP - 1444

JO - CLIN INFECT DIS

JF - CLIN INFECT DIS

SN - 1058-4838

IS - 9

ER -